X T L Biopharmaceuticals Ltd
XTLB0.784USD
+0.003+0.37%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
6.91MMarket Cap
LossP/E TTM
X T L Biopharmaceuticals Ltd Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
451.00K
--
EPS(YoY)
-0.15
53.21%
Analyst Rating
--
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its total revenue reached 451.00K, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its Earnings Per Share (EPS) was -0.153, with a year-on-year change of 53.21%.
What is the net income of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its net income was -1.03M, with a year-on-year change of 42.37%.
What is the net margin of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its net profit margin was -227.72%, with a year-on-year change of --.
What is the gross margin of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its gross margin was 0.67%, with a year-on-year change of --.
What is the debt-to-asset ratio of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its debt-to-asset ratio was 1.61%, with a year-on-year change of --.
What is the Return on Equity (ROE) of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its Return on Equity (ROE) was -26.83%, with a year-on-year change of 53.18%.
What is the Return on Assets (ROA) of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its Return on Assets (ROA) was -18.71%, with a year-on-year change of 65.28%.
What is the operating profit of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its operating profit was -2.17M, with a year-on-year change of -183.92%.
What are the current assets of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its current assets were 1.34M, with a year-on-year change of -34.51%.
What are the total assets of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its total assets of X T L Biopharmaceuticals Ltd were 8.55M, with a year-on-year change of 252.43%.
What are the total liabilities of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its total liabilities of X T L Biopharmaceuticals Ltd were 3.12M, with a year-on-year change of 1412.14%.
What is the total equity of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its total equity of X T L Biopharmaceuticals Ltd was 5.43M, with a year-on-year change of 144.82%.
What is the net operating income of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its net operating income of X T L Biopharmaceuticals Ltd was -1.03M, with a year-on-year change of 42.37%.
What is the net investment of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its net investment of X T L Biopharmaceuticals Ltd was -878.00K, with a year-on-year change of --.
What is the net financing of X T L Biopharmaceuticals Ltd?
According to X T L Biopharmaceuticals Ltd's FY2024 earnings report, its net financing of X T L Biopharmaceuticals Ltd was 1.45M, with a year-on-year change of --.
